Literature DB >> 8625327

Tumor necrosis factor alpha interferes with the cell cycle of normal and papillomavirus-immortalized human keratinocytes.

K B Vieira1, D J Goldstein, L L Villa.   

Abstract

We have shown that normal and human papillomavirus (HPV) type 16 immortalized human foreskin keratinocytes are growth inhibited by tumor necrosis factor alpha (TNF-alpha), whereas HPV-18- and SV40-immortalized keratinocytes are resistant to this cytokine (1). In this report, we investigated the expression of mitotic regulatory proteins, such as cyclin A, cyclin B, and p34cdc2. After exposure to TNF-alpha, normal and HPV-16-immortalized cells exhibited a dramatic decrease in the expression of these proteins. In contrast, no alteration in the levels of these proteins was observed after treatment of the resistant cell lines, as well as two HPV-positive cervical carcinoma cell lines. Expression of cyclin E does not seem to be modulated by TNF-alpha in any of the cells tested. On the other hand, cyclin D1, expression is slightly increased in normal keratinocytes and in the HPV-16-immortalized cells, whereas no alteration was observed in the HPV-18-transfected cells. The phosphorylation state of pRb correlated with cell growth; sensitive cells, which accumulate in G0-G1, after exposure to TNF-alpha, exhibited an accumulation of hypophosphorylated pRb, whereas no effect on pRb phosphorylation was observed for HPV-18-immortalized cells. These results clearly correlate with TNF-alpha-induced growth arrest in G0-G1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625327

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.

Authors:  Caiyun Zhang; Erich M Sturgis; Hongliang Zheng; Xicheng Song; Peng Wei; Lei Jin; Li Chao; Qingyi Wei; Guojun Li
Journal:  Int J Cancer       Date:  2013-10-24       Impact factor: 7.396

3.  Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil.

Authors:  R T Simões; M A G Gonçalves; E A Donadi; A L Simões; J S R Bettini; G Duarte; S M Quintana; M W P Carvalho; E G Soares
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

4.  The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-κB signaling.

Authors:  Wei Wang; Mingxiong Guo; Li Hu; Jinyang Cai; Yan Zeng; Jun Luo; Zhiqiang Shu; Wenxin Li; Zan Huang
Journal:  J Biol Chem       Date:  2012-10-22       Impact factor: 5.157

Review 5.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

6.  Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.

Authors:  Devan Prabhavathy; Chandrasekaran Karthik Subramanian; Devarajan Karunagaran
Journal:  Biosci Rep       Date:  2015-02-25       Impact factor: 3.840

7.  Genetic susceptibility of cervical cancer.

Authors:  Xiaojun Chen; Jie Jiang; Hongbing Shen; Zhibin Hu
Journal:  J Biomed Res       Date:  2011-05

8.  Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis.

Authors:  Nicolae-Costin Diaconu; Jaana Rummukainen; Mikko Mättö; Anita Naukkarinen; Rauno J Harvima; Jukka Pelkonen; Ilkka T Harvima
Journal:  BMC Cancer       Date:  2008-02-07       Impact factor: 4.430

9.  Characterization of global transcription profile of normal and HPV-immortalized keratinocytes and their response to TNF treatment.

Authors:  Lara Termini; Enrique Boccardo; Gustavo H Esteves; Roberto Hirata; Waleska K Martins; Anna Estela L Colo; E Jordão Neves; Luisa Lina Villa; Luiz Fl Reis
Journal:  BMC Med Genomics       Date:  2008-06-27       Impact factor: 3.063

Review 10.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.